I have recently made some changes in my oref1-based AID/loop system which have dramatically improved the behaviour with Lyumjev. And it seemed those changes may also apply to Humalog, so it was time to test it out. Insulin models This is not about some fancy new algorithm, it’s just about optimising the insulin activity profile …
I’ve written in the past about the fact that Fiasp is not available in Penfill format in Australia, and this is still the case. Recap NovoRapid is available in 3 formats: 10 mL vials intended for syringe and pump use. Disposable 3 mL FlexPens. 3 mL Penfill cartridges which can be put into pens like …
A long word that basically means “too much insulin in the blood”. Hyperinsulinaemia is especially associated with Type 2 Diabetes and insulin resistance, where the body’s response to insulin is reduced, and higher-than-normal insulin levels are needed to get the required effect. But it can apparently also be involved with Type 1 (allegedly not just …
Faster insulins can be dramatically useful for AID (Automated Insulin Delivery) systems. Anything that reduces latency within the loop can improve our overall glycaemic control. A topic often discussed amongst people looking to get faster insulins is the possibility of mixing insulins in pumps. I do have to be clear and point out that this …
Back in December I wrote about some of my experiences using ultra-rapid Lyumjev insulin in my closed-loop system, but there were a couple of unanswered questions. Particularly to do with “bolus stings” and with the speed/activity of Lyumjev. I’ve now done some further work which has hopefully clarified those questions. Just to re-iterate for the …
A long-acting insulin that almost everyone (in the Australian T1 diabetes world anyway) knows of is “Lantus”, even though it was replaced by the identical Optisulin 2 years ago. It took a while to be phased out. A few months prior (back in October 2019) I reported the arrival of “Semglee”. This is marketed by …